Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Carboplatin in Cervical Cancer
NCT00600210Phase 2Withdrawn
- Sponsor
- Leo W. Jenkins Cancer Center
- Start
- Jan 2008
- Primary completion
- Apr 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Cervical Cancer (CC), sponsored by Leo W. Jenkins Cancer Center. Planned start Jan 2008; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00600210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600210.